Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 5,000 shares at $20.00 ($100K) on 2018-06-12, disclosed to the SEC on 2018-06-12.
Open-market sale of $100k ACRS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 100 | $2K | 2.0% |
| 2 | $20.00 | 4,900 | $98K | 98.0% |
| Total | $20.00 avg | 5,000 | $100K | 100% |
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |